PDGFRA and gastrointestinal stromal tumor: A GIST occurs predominantly in the stomach (50–60%) and small intestine (30–35%) and is mainly driven by activating mutations (present in 85–90% of patients) in the receptor tyrosine kinases KIT and platelet-derived growth factor receptor A (PDGFRA).